Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial
Daniel Peter Petrylak, Ronald de Wit, Kim N. Chi et al. · The Lancet · 2017
Cited by 171 works. doi:10.1016/s0140-6736(17)32365-6 Open-access PDF
Authors
- Daniel Peter Petrylak
- Ronald de Wit
- Kim N. Chi
- Alexandra Drakaki
- Cora Nanette Sternberg
- Hiroyuki Nishiyama
- Daniel Castellano
- Syed A. Hussain
- Aude Fléchon
- Aristotelis Bamias
- Evan Y. Yu
- Michiel S. van der Heijden
- Nobuaki Matsubara
- B. Yа. Alekseev
- Andrea Necchi
- Lajos Géczi
- Yen‐Chuan Ou
- Hasan Şenol Çoşkun
- Wen-Pin Su
- Miriam Hegemann
References
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
- Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
- A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.
- Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse
- 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline
- Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
- Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
- Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.
- Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract